Drug dosing during continuous renal replacement therapy

Seminars in Dialysis

Volumn 22, Issue 2, 2009, Pages 185-188

  Churchwell, Mariann D ^b   Mueller, Bruce A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CREATININE; DAPTOMYCIN; GENTAMICIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BACTEREMIA; BLOOD; CASE REPORT; DRUG COMBINATION; FOLLOW UP; HUMAN; MALE; METABOLISM; METHODOLOGY; RENAL REPLACEMENT THERAPY; SURGICAL INFECTION; URINE;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CREATININE; DAPTOMYCIN; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GENTAMICINS; HUMANS; KIDNEY FAILURE, ACUTE; MALE; RENAL REPLACEMENT THERAPY; SURGICAL WOUND INFECTION;

EID: 65449126279     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2008.00541.x     Document Type: Article

References (24)

1. Joy MS, Matzke GR, Armstrong DK, Marx MA, Zarowitz BJ : A primer on continuous renal replacement therapy for critically ill patients. Ann Pharmacother 32 : 362 375, 1998
2. Vilay AM, Churchwell MD, Mueller BA : Drug metabolism and clearance in acute kidney injury. Crit Care 12 : 235 (doi : 2008
3. Nolin TD, Naud J, Leblond FA, Pichette V : Emerging evidence of the impact of kidney disease on drug metabolism and transport. Clin Pharmacol Ther 83 : 898 903, 2008
4. Mueller BA, Scarim SK, Macias WL : Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration. Am J Kidney Dis 21 : 172 179, 1993
5. Nolin TD, Appiah K, Kendrick SA, Le P, McMonagle E, Himmelfarb J : Hemodialysis acutely improves hepatic CYP3A4 metabolic activity. J Am Soc Nephrol 17 : 2363 2367, 2006
6. Mueller BA, Pasko DA, Sowinski KM : Higher renal replacement therapy dose delivery influences on drug therapy. Artif Organs 27 : 808 814, 2003
7. Joy MS, Matzke GR, Frye RF, Palevsky PM : Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. Am J Kidney Dis 31 : 1019 1027, 1998
8. Churchwell MD, Pasko DA, Mueller BA : Daptomycin clearance during modeled continuous renal replacement therapy. Blood Purif 24 : 548 554, 2006
9. Uchino S, Cole L, Morimatsu H, Goldsmith D, Bellomo R : Clearance of vancomycin during high-volume haemofiltration: impact of pre-dilution. Intensive Care Med 28 : 1664 1667, 2002
10. Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J : Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 34 : 486 492, 1999
11. Pasko DA, Churchwell MD, Mueller BA : Duration of Continuous Venovenous Hemodialysis and Dialysate Flow Rate on Solute Saturation Coefficient (abstract). European Society of Clinical Pharmacy Conference, 2004, Paris, France
12. Pasko DA, Churchwell MD, Mueller BA : Duration of Continuous Hemofiltration and Ultrafiltration Rate Influence on Sieving Coefficients (abstract). European Society of Clinical Pharmacy Conference, 2004, Paris, France
13. Zaske DE, Cipole RJ, Rotschafer JC, Solem LD, Mosier NR, Strate RG : Gentamicin pharmacokinetics in 1640 patients: methods for control of serum concentrations. Antimicrob Agents Chemother 21 : 407 411, 1982
14. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R : Experience with a once-daily aminoglycoside program administered to 2184 adult patients. Antimicrob Agents Chemother 39 : 650 655, 1995
15. Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA : Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Intensive Care Med 28 : 936 942, 2002
16. Dvorchik B, Arbeit RD, Chung J, Liu S, Knebel W, Kastrissios H : Population pharmacokinetics of daptomycin. Antimicrob Agents Chemother 48 : 2799 2807, 2004
17. Cubist Pharmaceuticals, Inc. Cubicin (Daptomycin for Injection) Package Insert. Lexington MA : Cubist Pharmaceuticals, Inc., 2007.
18. Vilay AM, Grio MC, DePestel DD, Sowinski KM, Gao L, Salama NN, Mueller BA : Daptomycin Pharmacokinetics in Patients Treated With Continuous Venovenous Hemodialysis (CVVHD) (abstract). American Society of Nephrology Renal Week, 2008, Philadelphia, PA
19. Bush LM, Boscia JA, Wendeler M, Pitsakis PG, Kaye D : In vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 33 : 1198 1200, 1989
20. Hanberger H, Nilsson LE, Maller R, Isaksson B : Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs. Antimicrob Agents Chemother 35 : 1710 1716, 1991
21. Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, Pasko DA, Smoyer WE : Drug Prescribing in Renal Failure Dosing Guidelines for Adults and Children, 5th edn. Philadelphia : American College of Physicians, 2007
22. Micromedex : Micromedex® Healthcare Series (electronic version). Greenwood Village, CO : Thomson Micromedex. Available at http://www.thomsonhc. com, accessed August 26, 2008
23. Vidal L, Shavit M, Fraser A, Paul M, Leibovici L : Systematic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ 331 : 263 (doi :, published May 19, 2005), 2005
24. Aronoff GR : Dose adjustment in renal impairment: response from drug prescribing in renal failure. BMJ 30 : 331, 2005